Ikarian Capital »

Airsculpt Technologies shares owned by Ikarian Capital

Quarter-by-quarter ownership of Airsculpt Technologies (AIRS) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Airsculpt Technologies

Tip: Access up to 7 years of quarterly data

All positions including Airsculpt Technologies held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Airsculpt Technologies by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $144k 18k 8.02
2025-06-30 $87k 18k 4.83

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Airsculpt Technologies

Vesey Street Capital Partners
SW Investment Management
Balyasny Asset Management
Susquehanna International
BlackRock
OZ Management
National Bank Of Canada /fi/
Vanguard Group
FourWorld Capital Management
Geode Capital Management
CenterBook Partners
State Street Corporation
Citizens Financial Group
D. E. Shaw & Co
Divisadero Street Capital Management

View all funds holding Airsculpt Technologies